AVGO heads into its June 3 earnings with a clean short-interest picture, a fresh analyst target raise from Citigroup, and insider selling from the spring that now looks like routine plan activity rather than a warning sign.
The most notable development this week came from the Street. Citigroup's Atif Malik raised his price target on Broadcom to $500, up from $475, while maintaining a Buy rating — the only active target change among a crowded group of analysts who have otherwise stayed put. The broader analyst cohort is firmly constructive: JP Morgan, Wells Fargo, Bernstein, and Cantor Fitzgerald all hold positive ratings with targets ranging from $430 to $525. The consensus mean target is $476, implying roughly 13.5% upside from the current close of $419.30. The one dissent was Seaport Global, which downgraded to Neutral in early April — a lone voice on the sidelines that hasn't moved the needle on overall sentiment. Bulls point to Broadcom's AI networking dominance, multi-year capacity commitments, and infrastructure software stability. Bears flag geopolitical export risk, hyperscaler competition, and a valuation that already prices in much of the AI growth story.
Short positioning is thin and getting thinner — this is not a stock with a meaningful bear-in-the-market narrative. Short interest dropped 4.5% over the past week to just 1.1% of the free float, its lowest level in over a month. Days to cover, per the official FINRA filing, is a negligible 2.6 days. The borrow market is relaxed: the cost to borrow is running at 0.40% — rock-bottom, despite a sharp-looking 159% week-on-week change that reflects a jump from an anomalously low 0.12% mid-week print rather than any genuine stress. Availability of shares to borrow is ample, and the ORTEX short score is a mild 29.6 out of 100. There is no squeeze setup here, and no signs of shorts pressing a view into earnings.
Options positioning is similarly unexcited, though slightly defensive. The put/call ratio is 1.12, a touch below its 20-day average of 1.14 — making this actually one of the less bearish readings of the past month. The z-score of -1.15 confirms options markets are incrementally less hedged than normal, not more. The 52-week PCR range spans 0.89 to 1.23, so the current level is squarely in the middle. RSI14 is 59.7 — rising but not overbought. The stock is up 13% over the past month and down 1.9% on the week, mirroring a rough session for peers: MRVL shed 2.5% on the week, and ALAB fell 5.2%, while SMTC bucked the tape with a 17% surge.
The insider slate from the spring is worth noting but not alarming. Chairman Henry Samueli sold roughly 206,000 shares across three trades in late March, raising around $66 million. Several divisional presidents also sold in early April as the stock traded in the $345–$400 range. The net 90-day insider position is mildly positive in share count terms, suggesting these were pre-planned sales into strength rather than a co-ordinated exit. Top institutional holders — Vanguard at 10.2%, BlackRock at 8.0%, and Capital Research at 7.5% — all added to positions in their most recent filings, with State Street the most active buyer, adding over 5 million shares.
With earnings scheduled for June 3, the recent price history shows a mixed reaction pattern: the last three prints produced a +6.0%, -3.3%, and -1.1% next-day move respectively. The 5-day follow-through has been more decisive — the March 2026 earnings drove an 8.8% five-day rally, while the December 2025 event led to a 7.6% five-day drawdown. The setup into this quarter is relatively clean: shorts are low, borrow is cheap, the Street is positively skewed, and options traders aren't loading up on downside. What matters most in three weeks is whether AI networking revenue growth continues to outpace the market's already elevated expectations.
See the live data behind this article on ORTEX.
Open AVGO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
